I agree that this site is using cookies. You can find further informations here.
X
Melgosa Ramos, F Javier
34  results:
Search for persons X
?
1

Efficacy of omalizumab for the treatment of bullous pemphig..:

Aguado Vázquez, Álvaro ; Estébanez Corrales, Andrea ; Melgosa Ramos, F Javier...
Clinical and Experimental Dermatology.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Upadacitinib effectiveness in moderate‐to‐severe atopic der..:

Melgosa Ramos, F. Javier ; González‐Delgado, Víctor ; Motilla, José María Sánchez...
Australasian Journal of Dermatology.  64 (2023)  4 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
3

Acral haemorrhage after the second dose administration of S..:

Melgosa Ramos, F. Javier ; Estébanez Corrales, Andrea ; Mateu Puchades, Almudena
Medicina Clínica (English Edition).  157 (2021)  10 - p. 506 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Validation of a Histologic Scoring Index for C3 Glomerulopa..:

Caravaca-Fontán, Fernando ; Trujillo, Hernando ; Alonso, Marina...
American Journal of Kidney Diseases.  77 (2021)  5 - p. 684-695.e1 , 2021
Link: https://doi.org/10.1053/..
 
?
5

Bestimmende Faktoren für die Therapie der dissezierenden Ze..:

Melgosa Ramos, Francisco Javier ; Berna‐Rico, Emilio ; Suarez‐Valle, Ana...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft.  22 (2024)  1 - p. 115-117 , 2024
Link: https://doi.org/10.1111/..
 
?
6

Long‐term secukinumab efficacy and safety in bio‐naïve pati..:

Melgosa Ramos, Francisco Javier ; Mateu Puchades, Almudena ; Guillén Climent, Santiago...
JEADV Clinical Practice.  2 (2023)  3 - p. 576-582 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Cutaneous metastasis of mixed neuroendocrine, sarcomatous, ..:

Melgosa Ramos, Francisco Javier ; Revilla‐Nebreda, David ; Revellés Peñas, Leonor...
Journal of Cutaneous Pathology.  50 (2023)  11 - p. 935-937 , 2023
Link: https://doi.org/10.1111/..
 
?
8

Ausencia congénita de piel (síndrome de Bart) en un pacient..:

Melgosa Ramos, Francisco Javier ; Díaz Corpas, Tania ; Estébanez Corrales, Andrea.
Anales de Pediatría.  99 (2023)  6 - p. 447-448 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Determinant factors of biological therapy for dissecting ce..:

Melgosa Ramos, Francisco Javier ; Berna‐Rico, Emilio ; Suarez‐Valle, Ana...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft.  22 (2023)  1 - p. 115-117 , 2023
Link: https://doi.org/10.1111/..
 
?
10

Skin lesions due to monkeypox virus in a well-controlled HI..:

Melgosa Ramos, Francisco Javier ; Parra Civera, Marina ; Pons Fuster, Jesús José
Medicina Clínica (English Edition).  159 (2022)  12 - p. e87-e88 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Hand ulcers and cutaneous leucocytoclastic vasculitis secon..:

Melgosa Ramos, Francisco Javier ; Estebánez Corrales, Andrea ; Mateu Puchades, Almudena
Medicina Clínica (English Edition).  158 (2022)  11 - p. e4-e5 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Long‐term secukinumab efficacy in patients with moderate to..:

Melgosa Ramos, Francisco Javier ; García Ruiz, Ramón ; Estébanez Corrales, Andrea.
Journal of the European Academy of Dermatology and Venereology.  37 (2022)  4 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
13

Mid-Term Efficacy of Dupilumab in Children Aged ≥ 36 Months..:

Melgosa Ramos, F.J. ; Díaz Corpas, T. ; Martín Jiménez, S..
Actas Dermo-Sifiliográficas.  115 (2024)  6 - p. 625-627 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Olmesartan Associated Enteropathy as an Inflammatory Bowel ..:

Melgosa Ramos, F.J. ; García Ruiz, R. ; Mateu Puchades, A.
Actas Dermo-Sifiliográficas.  115 (2024)  6 - p. 607-608 , 2024
Link: https://doi.org/10.1016/..
 
?
15

52-Week Mid-term Efficacy of Tildrakizumab in Moderate-to-s..:

Melgosa Ramos, F.J. ; Mateu Puchades, A. ; Matáix-Díaz, J....
Actas Dermo-Sifiliográficas.  115 (2024)  7 - p. 722-726 , 2024
Link: https://doi.org/10.1016/..
 
1-15